The European Medicines Agency will get a second chance to argue that Brexit really is a frustrating event, after the judge who last week ruled against it on its property dispute with Canary Wharf Group granted it permission to
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.